{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:54:44Z","timestamp":1791568484767,"version":"4.3.4"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.exphem.2026.105870","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:37:52Z","timestamp":1787701072000},"page":"105870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prognostic model based on calcium-related genes predicts prognosis and reveals the immune landscape of acute myeloid leukemia"],"prefix":"10.1016","volume":"162","author":[{"given":"Jing","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2026.105870_bib0001","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","article-title":"Acute myeloid leukaemia","volume":"392","author":"Short","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2026.105870_bib0002","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev."},{"key":"10.1016\/j.exphem.2026.105870_bib0003","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","article-title":"Recent advances in targeted therapies in acute myeloid leukemia","volume":"16","author":"Bhansali","year":"2023","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.exphem.2026.105870_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116585","article-title":"The landscape of novel strategies for acute myeloid leukemia treatment: therapeutic trends, challenges, and future directions","volume":"473","author":"Wu","year":"2023","journal-title":"Toxicol Appl Pharmacol."},{"key":"10.1016\/j.exphem.2026.105870_bib0005","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/leu.2016.48","article-title":"Prediction of CR following a second course of '7+3\u2032 in patients with newly diagnosed acute myeloid leukemia not in CR after a first course","volume":"30","author":"Othus","year":"2016","journal-title":"Leukemia."},{"key":"10.1016\/j.exphem.2026.105870_bib0006","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/cncr.33477","article-title":"Acute myeloid leukemia: treatment and research outlook for 2021 and the MD Anderson approach","volume":"127","author":"Kantarjian","year":"2021","journal-title":"Cancer."},{"key":"10.1016\/j.exphem.2026.105870_bib0007","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00277-018-3584-2","article-title":"Allogeneic hematopoietic stem cells transplantation improves the survival of intermediate-risk acute myeloid leukemia patients aged less than 60 years","volume":"98","author":"Zhang","year":"2019","journal-title":"Ann Hematol."},{"key":"10.1016\/j.exphem.2026.105870_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1005031","article-title":"Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"13","author":"Mushtaq","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.exphem.2026.105870_bib0009","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/bloodadvances.2019001181","article-title":"Single-cell mutational profiling enhances the clinical evaluation of AML MRD","volume":"4","author":"Ediriwickrema","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.exphem.2026.105870_bib0010","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s12094-021-02621-w","article-title":"Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia","volume":"23","author":"Narayanan","year":"2021","journal-title":"Clin Transl Oncol."},{"key":"10.1016\/j.exphem.2026.105870_bib0011","article-title":"Improved treatment outcomes with modified induction therapy in acute myeloid leukemia (AML): a retrospective observational study from a regional cancer center","volume":"16","author":"Iqbal","year":"2024","journal-title":"Cureus."},{"key":"10.1016\/j.exphem.2026.105870_bib0012","unstructured":"NIH. Cancer Stat Facts: leukemia \u2014 acute myeloid leukemia (AML). https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html. Accessed September 14, 2026."},{"key":"10.1016\/j.exphem.2026.105870_bib0013","article-title":"Identification and validation of a novel CD8+ T cell-associated prognostic model based on ferroptosis in acute myeloid leukemia","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.exphem.2026.105870_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2023.107404","article-title":"A new prognostic risk model for acute myeloid leukemia patients based on telomere-related genes","volume":"135","author":"Zhang","year":"2023","journal-title":"Leuk Res."},{"key":"10.1016\/j.exphem.2026.105870_bib0015","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/s41467-021-22625-y","article-title":"A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia","volume":"12","author":"Docking","year":"2021","journal-title":"Nat Commun."},{"key":"10.1016\/j.exphem.2026.105870_bib0016","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a035204","article-title":"The calcium signaling toolkit in cancer: remodeling and targeting","volume":"11","author":"Roberts-Thomson","year":"2019","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"10.1016\/j.exphem.2026.105870_bib0017","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tcb.2022.07.004","article-title":"Calcium homeostasis and cancer: insights from endoplasmic reticulum-centered organelle communications","volume":"33","author":"Zheng","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.exphem.2026.105870_bib0018","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.canlet.2021.07.017","article-title":"Calcium channel TRPV6 promotes breast cancer metastasis by NFATC2IP","volume":"519","author":"Xu","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.exphem.2026.105870_bib0019","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41585-023-00738-x","article-title":"Calcium signalling pathways in prostate cancer initiation and progression","volume":"20","author":"Silvestri","year":"2023","journal-title":"Nat Rev Urol."},{"key":"10.1016\/j.exphem.2026.105870_bib0020","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.7150\/ijbs.68591","article-title":"Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmacological intervention","volume":"18","author":"Huang","year":"2022","journal-title":"Int J Biol Sci."},{"key":"10.1016\/j.exphem.2026.105870_bib0021","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/cells11030543","article-title":"Put in a \"Ca(2+)ll\" to acute myeloid leukemia","volume":"11","author":"Lewuillon","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.exphem.2026.105870_bib0022","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3390\/molecules26051323","article-title":"Pathogenic roles of S100A8 and S100A9 proteins in acute myeloid and lymphoid leukemia: clinical and therapeutic impacts","volume":"26","author":"Mondet","year":"2021","journal-title":"Molecules."},{"key":"10.1016\/j.exphem.2026.105870_bib0023","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jfma.2022.11.003","article-title":"The clinical and biological characterization of acute myeloid leukemia patients with S100A4 overexpression","volume":"122","author":"Yao","year":"2023","journal-title":"J Formos Med Assoc."},{"key":"10.1016\/j.exphem.2026.105870_bib0024","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2147\/JIR.S403928","article-title":"Construction of the interaction network of hub genes in the progression of Barrett's esophagus to esophageal adenocarcinoma","volume":"16","author":"Li","year":"2023","journal-title":"J Inflamm Res."},{"key":"10.1016\/j.exphem.2026.105870_bib0025","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2025.2577849","article-title":"Multi-omics and machine learning identify FN1 and ALDH2 as diagnostic biomarkers and therapeutic targets in early and late diabetic kidney disease","volume":"47","author":"Lin","year":"2025","journal-title":"Ren Fail."},{"key":"10.1016\/j.exphem.2026.105870_bib0026","article-title":"THBS1, a fatty acid-related metabolic gene, can promote the development of laryngeal cancer","volume":"12","author":"Ji","year":"2022","journal-title":"Sci Rep."},{"key":"10.1016\/j.exphem.2026.105870_bib0027","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6439975","article-title":"Development and validation of a TNF family-based signature for predicting prognosis, tumor immune characteristics, and immunotherapy response in colorectal cancer patients","volume":"2021","author":"Xiao","year":"2021","journal-title":"J Immunol Res."},{"key":"10.1016\/j.exphem.2026.105870_bib0028","article-title":"Comprehensive analysis of transient receptor potential channels-related signature for prognosis, tumor immune microenvironment, and treatment response of colorectal cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.exphem.2026.105870_bib0029","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12944-022-01687-x","article-title":"A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia","volume":"21","author":"Zhang","year":"2022","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.exphem.2026.105870_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw."},{"key":"10.1016\/j.exphem.2026.105870_bib0031","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40246-022-00377-0","article-title":"A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer","volume":"16","author":"Liu","year":"2022","journal-title":"Hum Genomics."},{"key":"10.1016\/j.exphem.2026.105870_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.769409","article-title":"Transcriptomic and metabolomic profiling in Helicobacter pylori-induced gastric cancer identified prognosis- and immunotherapy-relevant gene signatures","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"10.1016\/j.exphem.2026.105870_bib0033","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/cancers15020544","article-title":"Revealing prognostic and immunotherapy-sensitive characteristics of a novel cuproptosis-related lncRNA model in hepatocellular carcinoma patients by genomic analysis","volume":"15","author":"Mao","year":"2023","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.exphem.2026.105870_bib0034","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med."},{"key":"10.1016\/j.exphem.2026.105870_bib0035","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cels.2021.07.002","article-title":"Deep computational analysis details dysregulation of eukaryotic translation initiation complex eIF4F in human cancers","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Syst."},{"key":"10.1016\/j.exphem.2026.105870_bib0036","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7116080","article-title":"Construction of prognostic risk model for small cell lung cancer based on immune-related genes","volume":"2022","author":"Deng","year":"2022","journal-title":"Comput Math Methods Med."},{"key":"10.1016\/j.exphem.2026.105870_bib0037","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12672-024-01025-w","article-title":"Elucidating the impact of parthanatos-related microRNAs on the tumoral immune microenvironment and clinical outcome in low-grade gliomas","volume":"15","author":"Zhu","year":"2024","journal-title":"Discov Oncol."},{"key":"10.1016\/j.exphem.2026.105870_bib0038","article-title":"Machine learning-based cell death signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma","volume":"103","author":"Li","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.exphem.2026.105870_bib0039","article-title":"Prognostic ferroptosis-related lncRNA signatures associated with immunotherapy and chemotherapy responses in patients with stomach cancer","volume":"12","author":"Lai","year":"2021","journal-title":"Front Genet."},{"key":"10.1016\/j.exphem.2026.105870_bib0040","article-title":"To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep."},{"key":"10.1016\/j.exphem.2026.105870_bib0041","article-title":"POLE -related gene signature predicts prognosis, immune feature, and drug therapy in human endometrioid carcinoma","volume":"10","author":"Qiu","year":"2024","journal-title":"Heliyon."},{"key":"10.1016\/j.exphem.2026.105870_bib0042","article-title":"Construction and validation of a RARRES3-based prognostic signature related to the specific immune microenvironment of pancreatic cancer","volume":"14","author":"Sun","year":"2024","journal-title":"Front Oncol."},{"key":"10.1016\/j.exphem.2026.105870_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101658","article-title":"A pan-cancer landscape of centromere proteins in tumorigenesis and anticancer drug sensitivity","volume":"31","author":"Shi","year":"2023","journal-title":"Transl Oncol."},{"key":"10.1016\/j.exphem.2026.105870_bib0044","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12967-019-2010-4","article-title":"Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data","volume":"17","author":"Xu","year":"2019","journal-title":"J Transl Med."},{"key":"10.1016\/j.exphem.2026.105870_bib0045","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1158\/0008-5472.CAN-12-1370","article-title":"CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set","volume":"72","author":"Reinhold","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.exphem.2026.105870_bib0046","article-title":"Discovery of paradoxical genes: reevaluating the prognostic impact of overexpressed genes in cancer","volume":"13","author":"Liu","year":"2025","journal-title":"Front Cell Dev Biol."},{"key":"10.1016\/j.exphem.2026.105870_bib0047","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000039285","article-title":"Acute myeloid leukemia with gastric carcinoma: a case report of a double malignancy","volume":"103","author":"Wan","year":"2024","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.exphem.2026.105870_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106029","article-title":"Acute myeloid leukemia: therapy resistance and a potential role for tetraspanin membrane scaffolds","volume":"137","author":"Floren","year":"2021","journal-title":"Int J Biochem Cell Biol."},{"key":"10.1016\/j.exphem.2026.105870_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1055841","article-title":"Prognostic and immunological significance of calcium-related gene signatures in renal clear cell carcinoma","volume":"13","author":"Liu","year":"2022","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.exphem.2026.105870_bib0050","article-title":"Calcium-related gene signatures may predict prognosis and level of immunosuppression in gliomas","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.exphem.2026.105870_bib0051","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.3390\/cells11193156","article-title":"Calcium-related genes predicting outcomes and serving as therapeutic targets in endometrial cancer","volume":"11","author":"Huang","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.exphem.2026.105870_bib0052","doi-asserted-by":"crossref","first-page":"fcac299","DOI":"10.1093\/braincomms\/fcac299","article-title":"Clinical and genetic characteristics of amyotrophic lateral sclerosis patients with ANXA11 variants","volume":"4","author":"Sung","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.exphem.2026.105870_bib0053","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1152\/physrev.00030.2001","article-title":"Annexins: from structure to function","volume":"82","author":"Gerke","year":"2002","journal-title":"Physiol Rev."},{"key":"10.1016\/j.exphem.2026.105870_bib0054","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s12094-019-02045-7","article-title":"Distinct prognostic values of Annexin family members expression in acute myeloid leukemia","volume":"21","author":"Niu","year":"2019","journal-title":"Clin Transl Oncol."},{"key":"10.1016\/j.exphem.2026.105870_bib0055","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5504475","article-title":"Subcellular proteome analysis reveals apoptotic vulnerability of T-cell acute lymphoblastic leukemia","volume":"2022","author":"Song","year":"2022","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.exphem.2026.105870_bib0056","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1080\/07391102.2017.1415821","article-title":"Combined pharmacophore, virtual screening and molecular dynamics studies to identify Bruton's tyrosine kinase inhibitors","volume":"36","author":"Sakthivel","year":"2018","journal-title":"J Biomol Struct Dyn."},{"key":"10.1016\/j.exphem.2026.105870_bib0057","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood-2013-06-511154","article-title":"Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia","volume":"123","author":"Rushworth","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.exphem.2026.105870_bib0058","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.canlet.2019.07.008","article-title":"Abivertinib, a novel BTK inhibitor: anti-leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemia","volume":"461","author":"Huang","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.exphem.2026.105870_bib0059","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1002\/1878-0261.12742","article-title":"Abivertinib synergistically strengthens the anti-leukemia activity of venetoclax in acute myeloid leukemia in a BTK-dependent manner","volume":"14","author":"Huang","year":"2020","journal-title":"Mol Oncol."},{"key":"10.1016\/j.exphem.2026.105870_bib0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13045-019-0821-7","article-title":"Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia","volume":"13","author":"Elgamal","year":"2020","journal-title":"J Hematol Oncol."},{"key":"10.1016\/j.exphem.2026.105870_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106479","article-title":"Design, synthesis and pharmacological characterization of aminopyrimidine derivatives as BTK\/FLT3 dual-target inhibitors against acute myeloid leukemia","volume":"134","author":"Ran","year":"2023","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.exphem.2026.105870_bib0062","doi-asserted-by":"crossref","DOI":"10.1038\/srep12949","article-title":"Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia","volume":"5","author":"Pillinger","year":"2015","journal-title":"Sci Rep."},{"key":"10.1016\/j.exphem.2026.105870_bib0063","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150871","article-title":"Inhibition of bromodomain extraterminal histone readers alleviates skin fibrosis in experimental models of scleroderma","volume":"7","author":"Vichaikul","year":"2022","journal-title":"JCI Insight."},{"key":"10.1016\/j.exphem.2026.105870_bib0064","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9601046","article-title":"Activation state-dependent substrate gating in Ca(2+)\/calmodulin-dependent protein kinase II","volume":"2017","author":"Johnson","year":"2017","journal-title":"Neural Plast."},{"key":"10.1016\/j.exphem.2026.105870_bib0065","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9437","article-title":"Searching for a signature involving 10 genes to predict the survival of patients with acute myelocytic leukemia through a combined multi-omics analysis","volume":"8","author":"Zhuang","year":"2020","journal-title":"PeerJ."},{"key":"10.1016\/j.exphem.2026.105870_bib0066","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.12659\/MSM.908106","article-title":"Polycyclic aromatic hydrocarbons from particulate matter 2.5 (PM2.5) in polluted air changes miRNA profile related to cardiovascular disease","volume":"24","author":"He","year":"2018","journal-title":"Med Sci Monit."},{"key":"10.1016\/j.exphem.2026.105870_bib0067","first-page":"4898","article-title":"An inflammatory response-related gene signature associated with immune status and prognosis of acute myeloid leukemia","volume":"14","author":"Wu","year":"2022","journal-title":"Am J Transl Res."},{"key":"10.1016\/j.exphem.2026.105870_bib0068","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/aps.2016.121","article-title":"The PI3K\/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia","volume":"38","author":"Deng","year":"2017","journal-title":"Acta Pharmacol Sin."},{"key":"10.1016\/j.exphem.2026.105870_bib0069","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13148-021-01133-2","article-title":"Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer","volume":"13","author":"Feng","year":"2021","journal-title":"Clin Epigenetics."},{"key":"10.1016\/j.exphem.2026.105870_bib0070","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12967-019-1904-5","article-title":"High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia","volume":"17","author":"Song","year":"2019","journal-title":"J Transl Med."},{"key":"10.1016\/j.exphem.2026.105870_bib0071","doi-asserted-by":"crossref","first-page":"393","DOI":"10.32604\/or.2023.031134","article-title":"Leveraging diverse cell death patterns to predict the clinical outcome of immune checkpoint therapy in lung adenocarcinoma: based on muti-omics analysis and vitro assay","volume":"32","author":"Liang","year":"2023","journal-title":"Oncol Res."},{"key":"10.1016\/j.exphem.2026.105870_bib0072","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1182\/blood.2022016033","article-title":"Proteomic and phosphoproteomic landscapes of acute myeloid leukemia","volume":"140","author":"Kramer","year":"2022","journal-title":"Blood."},{"key":"10.1016\/j.exphem.2026.105870_bib0073","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092143","article-title":"Proteomic studies of primary acute myeloid leukemia cells derived from patients before and during disease-stabilizing treatment based on all-trans retinoic acid and valproic acid","volume":"13","author":"Hernandez-Valladares","year":"2021","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.exphem.2026.105870_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2019.102111","article-title":"A structural overview of the ion channels of the TRPM family","volume":"85","author":"Huang","year":"2020","journal-title":"Cell Calcium."},{"key":"10.1016\/j.exphem.2026.105870_bib0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41581-023-00777-y","article-title":"TRPM channels in health and disease","volume":"20","author":"Chubanov","year":"2024","journal-title":"Nat Rev Nephrol."},{"key":"10.1016\/j.exphem.2026.105870_bib0076","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s12885-020-06903-4","article-title":"Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells","volume":"20","author":"Gil-Kulik","year":"2020","journal-title":"BMC Cancer."},{"key":"10.1016\/j.exphem.2026.105870_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113566","article-title":"Tegaserod maleate exhibits antileukemic activity by targeting TRPM8","volume":"154","author":"Xie","year":"2022","journal-title":"Biomed Pharmacother."},{"key":"10.1016\/j.exphem.2026.105870_bib0078","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1347741","article-title":"The structural properties of full-length annexin A11","volume":"11","author":"Dudas","year":"2024","journal-title":"Front Mol Biosci."},{"key":"10.1016\/j.exphem.2026.105870_bib0079","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.colsurfb.2018.11.017","article-title":"Characterization of neurocalcin delta membrane binding by biophysical methods","volume":"174","author":"Hoareau","year":"2019","journal-title":"Colloids Surf B Biointerfaces."},{"key":"10.1016\/j.exphem.2026.105870_bib0080","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jcp.29866","article-title":"Protein kinase C-delta interacts with and phosphorylates ARD1","volume":"236","author":"Chun","year":"2021","journal-title":"J Cell Physiol."},{"key":"10.1016\/j.exphem.2026.105870_bib0081","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jns.2015.11.041","article-title":"Increased expression of copine VI in patients with refractory epilepsy and a rat model","volume":"360","author":"Zhu","year":"2016","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.exphem.2026.105870_bib0082","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1523\/JNEUROSCI.1248-15.2015","article-title":"Reversal of aging-related neuronal Ca2+ dysregulation and cognitive impairment by delivery of a transgene encoding FK506-binding protein 12.6\/1b to the hippocampus","volume":"35","author":"Gant","year":"2015","journal-title":"J Neurosci."},{"key":"10.1016\/j.exphem.2026.105870_bib0083","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.isci.2019.03.030","article-title":"Vitamin K2-dependent GGCX and MGP are required for homeostatic calcium regulation of sperm maturation","volume":"14","author":"Ma","year":"2019","journal-title":"iScience."},{"key":"10.1016\/j.exphem.2026.105870_bib0084","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.yjmcc.2009.12.019","article-title":"KChIP2 attenuates cardiac hypertrophy through regulation of Ito and intracellular calcium signaling","volume":"48","author":"Jin","year":"2010","journal-title":"J Mol Cell Cardiol."},{"key":"10.1016\/j.exphem.2026.105870_bib0085","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1186\/s12887-020-02409-x","article-title":"Citrin deficiency mimicking mitochondrial depletion syndrome","volume":"20","author":"Grunert","year":"2020","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.exphem.2026.105870_bib0086","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/ni1001-939","article-title":"Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein","volume":"2","author":"Liu","year":"2001","journal-title":"Nat Immunol."},{"key":"10.1016\/j.exphem.2026.105870_bib0087","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41419-020-2553-6","article-title":"CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.exphem.2026.105870_bib0088","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13578-024-01276-8","article-title":"Integrative analysis of bulk and single-cell RNA sequencing reveals the gene expression profile and the critical signaling pathways of type II CPAM","volume":"14","author":"Li","year":"2024","journal-title":"Cell Biosci."},{"key":"10.1016\/j.exphem.2026.105870_bib0089","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3390\/cells11071190","article-title":"On the connections between TRPM channels and SOCE","volume":"11","author":"Souza Bomfim","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.exphem.2026.105870_bib0090","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.3390\/biomedicines11113001","article-title":"Role of Akt\/protein kinase B in cancer metastasis","volume":"11","author":"Islam","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.exphem.2026.105870_bib0091","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1158\/1535-7163.MCT-18-0478","article-title":"Pleiotropic action of novel Bruton's tyrosine kinase inhibitor BGB-3111 in mantle cell lymphoma","volume":"18","author":"Li","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.exphem.2026.105870_bib0092","first-page":"670","article-title":"[Clinical significance of USP5 expression level in acute myeloid leukemia and its regulatory effects on AKT\/mTOR\/4EBP1 signaling pathway]","volume":"32","author":"Tian","year":"2024","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.exphem.2026.105870_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117071","article-title":"A novel iheyamine A derivative L42 suppresses acute myeloid leukemia via dual regulation of the PI3K\/AKT\/FOXO3a axis and TNF signaling pathway","volume":"177","author":"Dinghuan","year":"2024","journal-title":"Biomed Pharmacother."},{"key":"10.1016\/j.exphem.2026.105870_bib0094","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/CAD.0000000000001608","article-title":"Rhein exerts anti-multidrug resistance in acute myeloid leukemia via targeting FTO to inhibit AKT\/mTOR","volume":"35","author":"Zhang","year":"2024","journal-title":"Anticancer Drugs."},{"key":"10.1016\/j.exphem.2026.105870_bib0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/s12885-024-12212-x","article-title":"UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K\/AKT activation","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cancer."},{"key":"10.1016\/j.exphem.2026.105870_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116982","article-title":"Decreasing of serine\/threonine kinase 39 has tumour inhibiting effects on acute myeloid leukaemia by impacting the PI3K\/AKT and Wnt\/beta-catenin signalling cascades","volume":"489","author":"Li","year":"2024","journal-title":"Toxicol Appl Pharmacol."},{"key":"10.1016\/j.exphem.2026.105870_bib0097","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11011-016-9805-2","article-title":"Loss of PPARalpha perpetuates sex differences in stroke reflected by peripheral immune mechanisms","volume":"31","author":"Dotson","year":"2016","journal-title":"Metab Brain Dis."},{"key":"10.1016\/j.exphem.2026.105870_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215997","article-title":"Therapeutic inhibition of PPARalpha-HIF1alpha-PGK1 signaling targets leukemia stem and progenitor cells in acute myeloid leukemia","volume":"554","author":"Zhou","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.exphem.2026.105870_bib0099","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41419-023-06075-6","article-title":"Bcl-2 inhibition combined with PPARalpha activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia","volume":"14","author":"Xie","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.exphem.2026.105870_bib0100","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.3390\/cells9091921","article-title":"Nuclear receptors as potential therapeutic targets for myeloid leukemia","volume":"9","author":"Pan","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.exphem.2026.105870_bib0101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2020.04.002","article-title":"Toll-like receptors: triggers of regulated cell death and promising targets for cancer therapy","volume":"223","author":"Yang","year":"2020","journal-title":"Immunol Lett."},{"key":"10.1016\/j.exphem.2026.105870_bib0102","article-title":"Revealing of TLR-9 gene polymorphisms by qPCR HRM technique and their influence on TLR-9 serum level in acute myeloid leukemia patients: case-control study","volume":"182","author":"Qasim","year":"2024","journal-title":"Cytokine."},{"key":"10.1016\/j.exphem.2026.105870_bib0103","article-title":"High-expression of the innate-immune related gene UNC93B1 predicts inferior outcomes in acute myeloid leukemia","volume":"14","author":"Li","year":"2023","journal-title":"Front Genet."},{"key":"10.1016\/j.exphem.2026.105870_bib0104","doi-asserted-by":"crossref","first-page":"67166","DOI":"10.18632\/oncotarget.11568","article-title":"CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo","volume":"7","author":"Mladenov","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.exphem.2026.105870_bib0105","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1080\/10428194.2020.1775208","article-title":"Fc gamma receptor expression serves as prognostic and diagnostic factor in AML","volume":"61","author":"Heitmann","year":"2020","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.exphem.2026.105870_bib0106","doi-asserted-by":"crossref","first-page":"162","DOI":"10.15386\/mpr-2732","article-title":"Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, lymphocyte to monocyte ratio and Systemic Inflammatory Index in sexually transmitted diseases","volume":"97","author":"Pintea-Trifu","year":"2024","journal-title":"Med Pharm Rep."},{"key":"10.1016\/j.exphem.2026.105870_bib0107","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1007\/s00277-024-05841-6","article-title":"Exploring and clinical validation of prognostic significance and therapeutic implications of copper homeostasis-related gene dysregulation in acute myeloid leukemia","volume":"103","author":"Abulimiti","year":"2024","journal-title":"Ann Hematol."},{"key":"10.1016\/j.exphem.2026.105870_bib0108","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038432","article-title":"Construction and validation of a necroptosis-related prognostic signature in acute myeloid leukemia","volume":"103","author":"Pan","year":"2024","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.exphem.2026.105870_bib0109","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.17862","article-title":"Prognostic role of chemokine-related genes in acute myeloid leukemia","volume":"12","author":"Hou","year":"2024","journal-title":"PeerJ."},{"key":"10.1016\/j.exphem.2026.105870_bib0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.999163","article-title":"Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML relapse","volume":"13","author":"Odak","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.exphem.2026.105870_bib0111","article-title":"A novel prognostic model based on pyroptosis signature in AML","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.exphem.2026.105870_bib0112","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-65345-1","article-title":"Establishment and verification of a TME prognosis scoring model based on the acute myeloid leukemia single-cell transcriptome","volume":"14","author":"Miao","year":"2024","journal-title":"Sci Rep."},{"key":"10.1016\/j.exphem.2026.105870_bib0113","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/1878-0261.12640","article-title":"CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML","volume":"14","author":"Waldeck","year":"2020","journal-title":"Mol Oncol."},{"key":"10.1016\/j.exphem.2026.105870_bib0114","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12935-022-02684-x","article-title":"ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemia","volume":"22","author":"Li","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.exphem.2026.105870_bib0115","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12185-013-1266-3","article-title":"Prognostic implications of CD14 positivity in acute myeloid leukemia arising from myelodysplastic syndrome","volume":"97","author":"Choi","year":"2013","journal-title":"Int J Hematol."},{"key":"10.1016\/j.exphem.2026.105870_bib0116","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/cncr.11693","article-title":"The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome","volume":"98","author":"Hock","year":"2003","journal-title":"Cancer."},{"key":"10.1016\/j.exphem.2026.105870_bib0117","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10428194.2018.1474521","article-title":"Clinical significance of HLA-E genotype and surface\/soluble expression levels between healthy individuals and patients with acute leukemia","volume":"60","author":"Xu","year":"2019","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.exphem.2026.105870_bib0118","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/leu.2016.210","article-title":"HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem cell transplantation","volume":"31","author":"Herr","year":"2017","journal-title":"Leukemia."},{"key":"10.1016\/j.exphem.2026.105870_bib0119","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/leu.2014.244","article-title":"Novel drugs for older patients with acute myeloid leukemia","volume":"29","author":"Montalban-Bravo","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2026.105870_bib0120","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1002\/cncr.30949","article-title":"Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies","volume":"123","author":"Abaza","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2026.105870_bib0121","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3390\/cancers11111794","article-title":"HDAC inhibitors in acute myeloid leukemia","volume":"11","author":"San Jose-Eneriz","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exphem.2026.105870_bib0122","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/bloodadvances.2018027409","article-title":"Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study","volume":"3","author":"Garcia-Manero","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.exphem.2026.105870_bib0123","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40360-020-0397-4","article-title":"New uracil analog U-332 is an inhibitor of NF-kappaB in 5-fluorouracil-resistant human leukemia HL-60 cell line","volume":"21","author":"Dlugosz-Pokorska","year":"2020","journal-title":"BMC Pharmacol Toxicol."},{"key":"10.1016\/j.exphem.2026.105870_bib0124","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.exphem.2026.105870_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114995","article-title":"5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy","volume":"246","author":"Valencia-Lazcano","year":"2023","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.exphem.2026.105870_bib0126","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/tox.22927","article-title":"Combinational treatment of 5-fluorouracil and casticin induces apoptosis in mouse leukemia WEHI-3 cells in vitro","volume":"35","author":"Cheng","year":"2020","journal-title":"Environ Toxicol."},{"key":"10.1016\/j.exphem.2026.105870_bib0127","article-title":"Construction of an acute myeloid leukemia prognostic model based on m6A-related efferocytosis-related genes","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.exphem.2026.105870_bib0128","article-title":"Establishment and validation of a gene mutation-based risk model for predicting prognosis and therapy response in acute myeloid leukemia","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.exphem.2026.105870_bib0129","doi-asserted-by":"crossref","first-page":"10182","DOI":"10.1096\/fj.201902922RR","article-title":"Erlotinib is effective against FLT3-ITD mutant AML and helps to overcome intratumoral heterogeneity via targeting FLT3 and Lyn","volume":"34","author":"Cao","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.exphem.2026.105870_bib0130","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bcp.2008.05.024","article-title":"Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison","volume":"76","author":"Boehrer","year":"2008","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.exphem.2026.105870_bib0131","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1038\/onc.2012.469","article-title":"Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia","volume":"32","author":"Lainey","year":"2013","journal-title":"Oncogene."},{"key":"10.1016\/j.exphem.2026.105870_bib0132","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1039\/C5CC00454C","article-title":"Linifanib\u2013a multi-targeted receptor tyrosine kinase inhibitor and a low molecular weight gelator","volume":"51","author":"Marlow","year":"2015","journal-title":"Chem Commun (Camb)."},{"key":"10.1016\/j.exphem.2026.105870_bib0133","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1158\/1535-7163.MCT-10-0904","article-title":"The multitargeted receptor tyrosine kinase inhibitor linifanib (ABT-869) induces apoptosis through an Akt and glycogen synthase kinase 3beta-dependent pathway","volume":"10","author":"Hernandez-Davies","year":"2011","journal-title":"Mol Cancer Ther."}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X26005035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X26005035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:23:42Z","timestamp":1791566622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X26005035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":133,"alternative-id":["S0301472X26005035"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2026.105870","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic model based on calcium-related genes predicts prognosis and reveals the immune landscape of acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2026.105870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of International Society for Experimental Hematology.","name":"copyright","label":"Copyright"}],"article-number":"105870"}}